Wednesday 25 June 2014

Strides Arcolab Update by Epic Research

Epic Update Strides Arcolab

Strides Arcolab has received ANDA approval for its skin drug Imiquimod Creme by United States Food & Drug Administration (USFDA). This is first product approval from Beltapharm, the company’s UFDA approved semi solids facility in Milan, Italy. The product will be marketed directly by Strides in the US market.



Real Time News & Trading Trends Keep Liking Epic Research Private Limited



FacebookTwitterYouTubePinterestLinkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH


0 comments:

Post a Comment

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Online Project management